Bone Marrow Immunometabolic Remodeling in Osteoporosis: From Systemic Risk Factors to Precision Intervention
Abstract
Osteoporosis has traditionally been viewed as a bone remodeling disorder characterized by excessive bone resorption and inadequate bone formation. However, this paradigm does not fully explain its systemic heterogeneity, persistent progression, or variable therapeutic responses. This review reconceptualizes osteoporosis as a systemic remodeling disorder driven by immunometabolic dysregulation within the bone marrow microenvironment. Upstream risk factors, including estrogen deficiency, inflammaging, gut microbiota dysbiosis, lipid dysmetabolism, and chronic low-grade inflammation, do not act solely on terminal osteoblasts or osteoclasts; instead, they are hierarchically translated within the marrow niche. These perturbations reshape hematopoietic lineage commitment, redirect Bone Marrow Mesenchymal Stem Cells(BMSC) osteogenic-adipogenic fate, promote pathological marrow adipose tissue expansion, and establish a pro-inflammatory, osteoclastogenic milieu through T helper 17 (Th17)/regulatory T (Treg) imbalance, monocyte/macrophage remodeling, inflammasome activation, and osteoclast metabolic reprogramming. Consequently, the marrow niche shifts from an osteogenesis-supportive state toward a self-reinforcing pathological ecosystem marked by enhanced resorption, impaired formation, and marrow adiposity. We further discuss emerging strategies involving microecological remodeling, immune phenotype correction, metabolic checkpoint modulation, BMSC fate regulation, and…
Read the paper
Related studies
- Irisin Enhances Osteoblast DifferentiationIn Vitro
- Glucocorticoids suppress Wnt16 expression in osteoblasts in vitro and in vivo
- Interaction between Schwann Cells and Osteoblasts In Vitro
- Administration of cinnamaldehyde promotes osteogenesis in ovariectomized rats and differentiation of osteoblast in vitro
- The Effect of the Major Components of Fructus Cnidii on Osteoblasts In Vitro
- Estrogen depletion alters osteogenic differentiation and matrix production by osteoblasts in vitro
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.